Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
CNTX

CNTX - Context Therapeutics Inc. Stock Price, Fair Value and News

$2.39+0.20 (+9.13%)
Market Closed

Price Targets

CNTX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CNTX Price Action

Last 7 days

45.7%

Last 30 days

97.5%

Last 90 days

111.5%

Trailing 12 Months

181.2%

CNTX RSI Chart

CNTX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

CNTX Valuation

Market Cap

219.6M

Price/Earnings (Trailing)

-8.3

Price/Free Cashflow

-9.81

CNTX Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

CNTX Fundamentals

CNTX Earnings

Earnings (TTM)

-26.4M

Earnings Growth (Yr)

44.48%

Earnings Growth (Qtr)

-9.81%

CNTX Profitability

Return on Equity

-36.13%

Return on Assets

-33.37%

Free Cashflow Yield

-10.19%

CNTX Investor Care

Shares Dilution (1Y)

22.51%

Diluted EPS (TTM)

-0.22

About Context Therapeutics Inc.

CNTX
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors in the United States. It develops CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
 CEO
 WEBSITEcontexttherapeutics.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES9

Context Therapeutics Inc. Frequently Asked Questions

CNTX is the stock ticker symbol of Context Therapeutics Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Context Therapeutics Inc. is 219.59 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check CNTX's fair value in chart for subscribers.

The fair value guage provides a quick view whether CNTX is over valued or under valued. Whether Context Therapeutics Inc. is cheap or expensive depends on the assumptions which impact Context Therapeutics Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CNTX.